April 13, 2011 -- Shanghai Pharmaceuticals Holding said its Hong Kong IPO has been given a go-ahead by the China Securities Regulatory Commission (CSRC). It must still secure permission from the Hong Kong Stock Exchange. The offering, which is expected to raise between $1.5 billion and $1.8 billion, has been pushed back to May from April, presumably because of bureaucratic delays. More details....
Stock Symbol: (SH: 601607)
